The rising prevalence of cancer across the globe is a key factor driving the growth of the oncolytic virus therapy market.
Founded year: | Not set |
Funding rounds: | Not set |
Total funding amount: | Not set |
Founded year: | Not set |
Funding rounds: | Not set |
Total funding amount: | Not set |